glp 1 and bulimia GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder nervosa)? A systematic review GLP-1 drugs treat eating disorders

GLP1 receptor agonists are emerging as a new pillar of care in diabetic kidney disease, offering renal and cardiovascular protection beyond glucose control

There are some studies which show promise, but its not a quick fix. Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more

Link between gut microbiota and health outcomes in inulin -treated obese patients: lessons from the Food4Gut multicenter randomized placebo-controlled trial

In dogs, paracetamol is a useful anti-inflammatory with a good safety record, causing a lower incidence of gastric ulceration than NSAIDs

Hakim, Lansdale G.S

Like BPC-157, this peptide traditionally requires injection